Session Details

F063 Pediatric Procedural Dermatology: Setting up for Success

Sat, Mar 9, 1:00 PM - 3:00 PM
Room 6C
2 CME Available Forum NEW
View Map

DESCRIPTION

Open admission to eligible categories, no tuition or ticket

There is a national need for more pediatric dermatologists, and the number of those specifically trained in dermatologic surgery is even lower. This session will offer a unique opportunity to hear from some of the very few pediatric dermatology surgeons in the US about their journey and have insight and advice on how to develop a pediatric procedural dermatology niche. The session will also review best surgical approaches for common pediatric indications (CMN, pilomatrixoma, JXG etc…) and management of surgical complications

LEARNING OBJECTIVES

1.

Select the best surgical approach for common pediatric indications.

2.

Detect and manage pediatric surgical complications

3.

Develop skills to help setting up a pediatric procedural dermatology service

SCHEDULE

9:00 PM

Pediatric Procedural Dermatology: Setting up for Success

SPEAKERS

Maria Gnarra Buethe, MD, PhD, FAAD

Maria Gnarra Buethe, MD, PhD, FAAD

Shireen V. Guide, MD, FAAD

Shireen V. Guide, MD, FAAD

Melinda Jen, MD, FAAD

Melinda Jen, MD, FAAD

Marissa McEneany

Marissa McEneany

Harper Price, MD, FAAD

Harper Price, MD, FAAD

Annette M. Wagner, MD, FAAD

Annette M. Wagner, MD, FAAD

SPEAKER DISCLOSURES

Maria Gnarra Buethe, MD, PhD, FAAD

No financial relationships exist with ineligible companies.

Shireen V. Guide, MD, FAAD

Arcutis Biotherapeutics – Investigator(Fees); Boehringer Ingelheim – Investigator(Fees); Castle Biosciences – Investigator(Fees); Dermavant Sciences, Inc. – Investigator(Fees); Incyte – Investigator(Fees); JEUNE Inc. – Investigator(Fees); Krystal Biotech, Inc – Speaker(Honoraria); Novartis – Investigator(Fees); Pfizer Inc. – Investigator(Fees); Sanofi Genzyme – Investigator(Fees);

Melinda Jen, MD, FAAD

No financial relationships exist with ineligible companies.

Marissa McEneany

No financial relationships exist with ineligible companies.

Harper Price, MD, FAAD

No financial relationships exist with ineligible companies.

Annette M. Wagner, MD, FAAD

No financial relationships exist with ineligible companies.